CollPlant Biotechnologies Ltd.

Healthcare · Biotechnology · Israel

Last price 4.135 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 7.82M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. Its products are based on its recombinant human collagen (rhCollagen) that is produced using its proprietary technology. The company offers regenerative dermal and soft tissue fillers; 3D-bioprinted regenerative breast implants; Collage, a combinant human Collagen type I solution; VergenixSTR, a soft tissue mat...